Celldex Therapeutics Stock Forward View - Price Action Indicator

CLDX Stock  USD 29.43  0.07  0.24%   
At present, RSI for Celldex Therapeutics stands at 58, indicating neutral momentum. Values near 50 generally reflect equilibrium between upward and downward pressure.
Momentum 58
 Buy Extended
 
Oversold
 
Overbought
Predicting Celldex Therapeutics' future price is a multi-variable problem that combines fundamental signals, technical structure, and market sentiment. This module focuses specifically on the hype and news dimension of that forecast.
This section relates Celldex Therapeutics headline activity to recent price behavior and peer context.
Celldex Therapeutics after-hype prediction price
    
  USD 29.43  
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Use Historical Fundamental Analysis of Celldex Therapeutics to cross-verify projections for Celldex Therapeutics. The historical view provides additional context.
For more information on how to buy Celldex Stock please use our How to Buy Celldex Stock guide.

Celldex Therapeutics Additional Predictive Modules

Most predictive techniques to examine Celldex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Celldex using various technical indicators. When you analyze Celldex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Celldex Therapeutics has current Price Action Indicator of 0.25. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Celldex Therapeutics VolatilityBacktest Celldex TherapeuticsInformation Ratio  

Celldex Therapeutics Trading Date Momentum

On March 09 2026 Celldex Therapeutics was traded for 29.43 at the closing time. The top price for the day was 29.81 and the lowest listed price was 28.62 . There was no trading activity during the period 0.0. Lack of trading volume on March 9, 2026 did not affect price variability. The overall trading delta against the current closing price is -2.11% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Celldex Therapeutics to competition

Other Forecasting Options for Celldex Therapeutics

Whether a novice or experienced investor, anyone considering Celldex needs to understand the dynamics of Celldex Therapeutics' price movement. Price charts for Celldex Stock contain a significant amount of noise that can distort investment decisions.

Celldex Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celldex Therapeutics stock to make a market-neutral strategy. Peer analysis of Celldex Therapeutics could also be used in its relative valuation, which is a method of valuing Celldex Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Celldex Therapeutics Market Strength Events

Analyzing market strength indicators for Celldex Therapeutics enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Celldex Therapeutics.

Celldex Therapeutics Risk Indicators

Identifying and analyzing Celldex Therapeutics' key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with Celldex Therapeutics' and decide how to manage it.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Celldex Therapeutics

Coverage intensity for Celldex Therapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

Celldex Therapeutics Short Properties

Short sentiment tied to Celldex Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding66.5 M
Cash And Short Term Investments518.6 M

More Resources for Celldex Stock Analysis

A structured review of Celldex Therapeutics often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Celldex Therapeutics Stock in context:
Use Historical Fundamental Analysis of Celldex Therapeutics to cross-verify projections for Celldex Therapeutics. The historical view provides additional context.
For more information on how to buy Celldex Stock please use our How to Buy Celldex Stock guide.
Analysis related to Celldex Therapeutics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
The market value of Celldex Therapeutics is measured differently than book value, which reflects Celldex accounting equity. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Market price responds to sentiment, liquidity, and macro shifts, so gaps can appear. Valuation work aligns these measures into a single context.
Note that Celldex Therapeutics' intrinsic value and market price are different measures derived from different inputs. Context can include financial performance, operating efficiency, market trends, and peer comparisons. Trading price represents the transaction level agreed by market participants.